Xeris Biopharma Holdings Inc (XERS)
Cash & Equivalents
$121.75M
Quarterly · Period ending: · USD
XERS Cash & Equivalents
Latest reported$121.75Mperiod ending
Latest reported$121.75Mperiod ending
XERS Quarterly Cash & Equivalents (-$32.27M → $121.75M)
Quarterly Cash & Equivalents
High-resolution chart · PNG
XERS cash & equivalents history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Cash & Equivalents (USD) |
|---|---|
| 121,747,000 | |
| 111,750,000 | |
| 111,042,000 | |
| 91,598,000 | |
| 59,285,000 | |
| 58,440,000 | |
| 71,621,000 | |
| 59,232,000 | |
| 57,604,000 | |
| 62,690,000 | |
| 67,449,000 | |
| 46,143,000 | |
| 46,170,000 | |
| 50,984,000 | |
| 121,966,000 | |
| 84,109,000 | |
| 95,340,000 | |
| 103,771,000 | |
| 67,271,000 | |
| 59,492,000 | |
| 63,599,000 | |
| 66,604,000 | |
| 37,598,000 | |
| 37,886,000 | |
| 102,465,000 | |
| 39,244,000 | |
| 19,519,000 | |
| 56,160,000 | |
| 66,669,000 | |
| 61,984,000 | |
| 45,716,000 | |
| 75,745,000 | |
| 134,528,000 | |
| 58,110,000 | |
| 42,045,000 | |
| -32,269,000 |